Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019

Use of Cannabinoids to Treat Acute Respiratory Distress Syndrome and Cytokine Storm Associated with Coronavirus Disease-2019

Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory disease caused by the severe acute respiratory syndrome coronavirus 2. A significant proportion of COVID-19 patients develop Acute Respiratory Distress Syndrome (ARDS) resulting from hyperactivation of the immune system and cytok...

Full description

Bibliographic Details
Main Authors: Prakash Nagarkatti, Kathryn Miranda, Mitzi Nagarkatti
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-11-01
Series:Frontiers in Pharmacology
Subjects:
severe acute respiratory syndrome coronavirus 2
coronavirus disease 2019
cannabinoid
acute respiratory distress syndrome
cytokine storm
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2020.589438/full

Internet

https://www.frontiersin.org/articles/10.3389/fphar.2020.589438/full

Similar Items